Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
145.5 USD | +0.06% | -1.05% | -7.15% |
06-14 | EU regulator mandates label updates on CAR-T cancer therapies | RE |
06-14 | J&J: encouraging trial in relapsing multiple myeloma | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-7.15% | 350B | |
+50.70% | 791B | |
+41.96% | 630B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson to Record $610 Million Impairment Charge in Q1 From Terminating Development of Atopic Dermatitis Drug